Showing results (131-140 of 158) with videos related to
Sort By:
Pageof 16
Molecular Oncology|May 26, 2017
K-Ras mutation and amplification status is predictive of resistance and high basal pAKT is predictive of sensitivity to everolimus in biliary tract cancer cell linesYvonne Yeung, David K Lau, Fiona Chionh, et al.Hepatobiliary & Pancreatic Diseases International : HBPD INT|November 3, 2022
A mixed blessing for liver transplantation patients - RapamycinGuang-Han Fan, Chen-Zhi Zhang, Feng-Qiang Gao, et al.Cancer Medicine|January 10, 2014
Treatment with the vascular disruptive agent OXi4503 induces an immediate and widespread epithelial to mesenchymal transition in the surviving tumorTheodora Fifis, Linh Nguyen, Cathy Malcontenti-Wilson, et al.Cancer Letters|December 21, 2019
Inhibition of PAK1 suppresses pancreatic cancer by stimulation of anti-tumour immunity through down-regulation of PD-L1Kai Wang, Yifan Zhan, Nhi Huynh, et al.Surgical Endoscopy|March 25, 2010
The diagnostic efficacy of natural orifice transluminal endoscopic surgery: is there a role in the intensive care unit?Joseph A Trunzo, Benjamin K Poulose, Michael F McGee, et al.Surgical Endoscopy|January 29, 2010
Peritoneal inflammatory response of natural orifice translumenal endoscopic surgery (NOTES) versus laparoscopy with carbon dioxide and air pneumoperitoneumJoseph A Trunzo, Michael F McGee, Leandro T Cavazzola, et al.ANZ Journal of Surgery|April 29, 2026
Timeliness of Care and Treatment Patterns for Pancreatic Cancer in Victoria, Australia: Comparison With Optimal Care Pathways TargetsSam Banks, Belinda Lee, Nadia Ayres, et al.Plos One|September 8, 2023
Multimodal intrathecal analgesia (MITA) with morphine for reducing postoperative opioid use and acute pain following hepato-pancreato-biliary surgery: A multicenter retrospective studyVidhura Ratnasekara, Laurence Weinberg, Samuel Anthony Johnston, et al.Therapeutics and Clinical Risk Management|October 17, 2025
Reduced Long-Term Survival After Postoperative Complications in Major Gastrointestinal SurgeryDaantje N Gratama, Laurence Weinberg, Nattaya Raykateeraroj, et al.European Journal of Cancer (Oxford, England : 1990)|August 21, 2022
Impact of first-line FOLFIRINOX versus Gemcitabine/Nab-Paclitaxel chemotherapy on survival in advanced pancreatic cancer: Evidence from the prospective international multicentre PURPLE pancreatic cancer registryJordan Santucci, Mark Tacey, Benjamin Thomson, et al.Pageof 16